ARCHIVES

Two-Drug Combination Extends Survival Of Mesothelioma

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

March 11, 2005

President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel

June 1, 2001

In congress: Senate Committee Approves 7.5 Percent Increase for NIH

July 25, 1997

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

May 29, 1998

NCI Programs: 15 New Grants Awarded In Survivor Research

October 9, 1998

DCT Board Okays Bladder Cancer RFA From Organ Systems Program

June 6, 1986